PVR update: pathophysiology and clinical management.
作者信息
Wiedemann Peter, Hui Yan-Nian
机构信息
Medical Faculty, Leipzig University, Leipzig 04103, Germany.
Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.
出版信息
Int J Ophthalmol. 2024 Sep 18;17(9):1577-1580. doi: 10.18240/ijo.2024.09.01. eCollection 2024.
Abstract
摘要
相似文献
1
PVR update: pathophysiology and clinical management.增殖性玻璃体视网膜病变的更新：病理生理学与临床管理
Int J Ophthalmol. 2024 Sep 18;17(9):1577-1580. doi: 10.18240/ijo.2024.09.01. eCollection 2024.
2
Clinical management of proliferative vitreoretinopathy: an update.增生性玻璃体视网膜病变的临床管理：最新进展
Retina. 2015 Feb;35(2):165-75. doi: 10.1097/IAE.0000000000000447.
3
Pulmonary Valve Replacement for Pulmonary Regurgitation in Adults With Tetralogy of Fallot: A Meta-analysis-A Report for the Writing Committee of the 2019 Update of the Canadian Cardiovascular Society Guidelines for the Management of Adults With Congenital Heart Disease.法洛四联症成人患者肺瓣反流的肺瓣置换：一项荟萃分析-加拿大心血管学会 2019 年成人先天性心脏病管理指南更新报告的撰写委员会报告。
Can J Cardiol. 2019 Dec;35(12):1772-1783. doi: 10.1016/j.cjca.2019.08.031. Epub 2019 Aug 29.
4
Translational and clinical advancements in management of proliferative vitreoretinopathy.增殖性玻璃体视网膜病变治疗中的转化与临床进展
Curr Opin Ophthalmol. 2022 May 1;33(3):219-227. doi: 10.1097/ICU.0000000000000840. Epub 2022 Feb 25.
5
Retinal Detachment and Proliferative Vitreoretinopathy.视网膜脱离与增殖性玻璃体视网膜病变
Dev Ophthalmol. 2016;55:154-62. doi: 10.1159/000438972. Epub 2015 Oct 26.
6
Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.单细胞蛋白质组学和增生性玻璃体视网膜病变患者眼内膜的转录特征分析。
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):17. doi: 10.1167/iovs.63.5.17.
7
Circadian Patterns in Postvoid Residual and Voided Percentage Among Older Women with Urinary Incontinence.老年尿失禁女性排尿后残余尿量及排尿百分比的昼夜节律模式
J Clin Med. 2020 Mar 27;9(4):922. doi: 10.3390/jcm9040922.
8
Increased pulmonary venous resistance in morbidly obese patients without daytime hypoxia: clinical utility of the pulmonary artery catheter.肺动脉导管在无日间低氧血症的病态肥胖患者中增加肺静脉阻力的临床应用
Anesthesiology. 2010 Sep;113(3):552-9. doi: 10.1097/ALN.0b013e3181e4f706.
9
Molecular Targets for Proliferative Vitreoretinopathy.增殖性玻璃体视网膜病变的分子靶点
Semin Ophthalmol. 2021 May 19;36(4):218-223. doi: 10.1080/08820538.2021.1890791. Epub 2021 Feb 22.
10
Ventricular pressure-volume loops obtained by 3D real-time echocardiography and mini pressure wire-a feasibility study.通过 3D 实时超声心动图和微型压力导丝获得的心室压力-容积环：一项可行性研究。
Clin Res Cardiol. 2013 Jun;102(6):427-38. doi: 10.1007/s00392-013-0548-3. Epub 2013 Feb 9.
引用本文的文献
1
Surgical Technique: Viscodissection for Managing Funnel Retinal Detachments.手术技术：用于处理漏斗状视网膜脱离的玻璃体分离术。
J Clin Med. 2025 Jun 20;14(13):4394. doi: 10.3390/jcm14134394.
本文引用的文献
1
Proliferative vitreoretinopathy: a revised concept of retinal injury and response.增殖性玻璃体视网膜病变：视网膜损伤和反应的新概念。
Br J Ophthalmol. 2024 Nov 22;108(12):1621-1626. doi: 10.1136/bjo-2023-324417.
2
Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.视网膜脱离中增殖性玻璃体视网膜病变的临床治疗。
Surv Ophthalmol. 2024 Jul-Aug;69(4):508-520. doi: 10.1016/j.survophthal.2024.03.007. Epub 2024 Mar 15.
3
Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial.早期玻璃体内注射曲安奈德抑制外伤性增生性玻璃体视网膜病变：一项随机临床试验。
Br J Ophthalmol. 2024 Jul 23;108(8):1161-1167. doi: 10.1136/bjo-2023-324318.
4
Risk factors for proliferative vitreoretinopathy after retinal detachment surgery: A systematic review and meta-analysis.视网膜脱离手术后增生性玻璃体视网膜病变的危险因素：系统评价和荟萃分析。
PLoS One. 2023 Oct 30;18(10):e0292698. doi: 10.1371/journal.pone.0292698. eCollection 2023.
5
Proliferative vitreoretinopathy: an update on the current and emerging treatment options.增殖性玻璃体视网膜病变：当前和新兴治疗选择的最新进展。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):679-687. doi: 10.1007/s00417-023-06264-1. Epub 2023 Oct 16.
6
UTILIZATION OF PREOPERATIVE MIDPERIPHERAL OPTICAL COHERENCE TOMOGRAPHY FOR TAILORED SURGICAL MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY.术前周边眼 OCT 对增殖性玻璃体视网膜病变的个体化手术治疗的应用。
Retin Cases Brief Rep. 2023 Sep 1;17(5):639-643. doi: 10.1097/ICB.0000000000001260.
7
The Effect of Combining Scleral Buckle Surgery with Pars Plana Vitrectomy for Treatment of Recurrent Retinal Detachment Secondary to Proliferative Vitreoretinopathy.巩膜扣带术联合玻璃体切割术治疗增殖性玻璃体视网膜病变继发复发性视网膜脱离的疗效
Beyoglu Eye J. 2023 May 1;8(2):91-96. doi: 10.14744/bej.2023.71224. eCollection 2023.
8
Primary Retinal Detachment Repair in Eyes Deemed High Risk for Proliferative Vitreoretinopathy: Surgical Outcomes in 389 Eyes.原发性视网膜脱离修复术在被认为存在增殖性玻璃体视网膜病变高风险的眼中：389 只眼中的手术结果。
Ophthalmol Retina. 2023 Nov;7(11):954-958. doi: 10.1016/j.oret.2023.07.009. Epub 2023 Jul 13.
9
Effect of Changes in Surgical Strategies for the Treatment of Primary Rhegmatogenous Retinal Detachment on Functional and Anatomical Outcomes: A Retrospective Analysis of 812 Cases from the Years 2004 to 2012.原发性孔源性视网膜脱离手术治疗策略变化对功能和解剖学预后的影响：对2004年至2012年812例病例的回顾性分析
J Clin Med. 2023 Mar 15;12(6):2278. doi: 10.3390/jcm12062278.
10
Steroid Drugs as an Adjunct for Reducing the Incidence of Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment Surgery: A Meta-Analysis of Randomized Controlled Studies.类固醇药物作为减少孔源性视网膜脱离手术后增殖性玻璃体视网膜病变发生率的辅助治疗：一项随机对照研究的荟萃分析。
Ophthalmic Res. 2023;66(1):599-610. doi: 10.1159/000529451. Epub 2023 Feb 8.
Zotero 插件